News
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
1d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
4don MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...
WASHINGTON — The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional protein-based option for the coronavirus — is sowing ...
In his weekend tweet, FDA’s Makary referred to the Novavax vaccine as “a new product,” presumably because it had been updated to match last year’s common coronavirus strain. “New ...
Kennedy Jr cast doubt on its efficacy. The Novavax vaccine is the only COVID-19 booster in the United States that does not use messenger RNA technology - which some states have begun to ban - and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results